Melanoma is a type of skin cancer that develops in melanocytes, the cells responsible for producing skin pigment. Understanding its stages helps explain how deeply the cancer has grown and whether it has spread to nearby lymph nodes or distant organs. Doctors use examination findings, biopsy results.
Melanoma is one of the more serious forms of skin cancer because it can spread to other parts of the body. Its stage describes the extent of the disease, including the thickness of the tumor, ulceration, and evidence of spread. Healthcare professionals use staging information to assess the condition and determine appropriate management.
Melanoma staging generally follows the TNM system, which evaluates the primary tumor, nearby lymph nodes, and distant metastasis. Stages range from 0 to IV. The specific stage is determined by clinical examination, pathology findings, and additional tests when necessary.
Stage 0: Also called melanoma in situ, this stage means abnormal melanoma cells remain confined to the epidermis, the outermost layer of the skin. They have not invaded deeper skin tissues.
Stage I: The melanoma is relatively thin and remains localized. Tumor thickness and ulceration help determine whether it is classified as stage IA or IB. There is no evidence of spread to distant organs.
Stage II: The melanoma remains localized but is thicker or has other high-risk features, such as ulceration. It is divided into stages IIA, IIB, and IIC according to tumor characteristics. No regional lymph node or distant spread is identified for these classifications.
During these stages, a skin examination and biopsy help establish the diagnosis. A pathologist evaluates the tissue sample to determine tumor thickness and other features that contribute to staging.
Advanced melanoma describes disease that has spread beyond the original tumor or developed features associated with a higher stage. The location and extent of spread influence the stage, treatment options, and follow-up recommendations. Not every patient requires the same set of diagnostic tests.
Stage III: Melanoma has spread to nearby lymph nodes, nearby skin areas, or lymphatic channels, depending on the specific classification. Doctors may use lymph node assessment, sentinel lymph node biopsy, and imaging when appropriate to evaluate the extent of disease.
Stage IV: The cancer has spread to distant parts of the body, such as the lungs, liver, brain, bones, or distant skin and lymph nodes. The exact sites of metastasis and other clinical factors help determine the treatment approach.
Staging may involve physical examinations, biopsy results, lymph node evaluation, and imaging studies. Molecular testing, including testing for certain gene changes such as BRAF, may also help guide treatment decisions in appropriate cases.
Treatment can vary by stage and individual circumstances. Localized melanoma is commonly treated with surgical removal, while some patients with higher-risk disease may be offered immunotherapy or targeted therapy. Advanced melanoma may be managed using immunotherapy, targeted medicines when suitable, surgery in selected situations, or radiation therapy for specific purposes.
Understanding melanoma stages provides useful information about the extent of the disease, but stage alone does not predict an individual's outcome with certainty. Tumor characteristics, overall health, treatment response, and other clinical factors also matter. Anyone who notices a changing mole, a new unusual skin growth, or a lesion that bleeds or changes in appearance should seek evaluation from a qualified healthcare professional.